Changes in Composition to Committeess

CLINUVEL PHARMACEUTICALS LTD today announced changes to the composition of its Audit & Risk Committee and to its Remuneration Committee.

Consequent to his retirement from the Board of Directors, Stan McLiesh will be replaced by Jeffrey Rosenfeld on the Audit & Risk Committee as a voting member.

Sue Smith and Karen Agersborg will join the Remuneration Committee as voting members, replacing Stan McLiesh and replacing the Chief Executive Officer, Philippe Wolgen.